专利号:US-12240808-B2 优先权日:2021-05-28 标 题 :Process for the synthesis of calebin-a and its intermediates 发明人:MAJEED MUHAMMED; NAGABHUSHANAM KALYANAM; MUTHUKAMAN NAGARAJAN; NAIDU PENTAKOTA PARADESI 权利人:MAJEED MUHAMMED; NAGABHUSHANAM KALYANAM; MUTHUKAMAN NAGARAJAN; NAIDU PENTAKOTA PARADESI 摘要:The invention discloses novel intermediates in the synthesis of Calebin A represented by formula 3. The invention also covers processes for the synthesis of Calebin-A and its analogs using compounds of formula 3.
专利号:US-6417290-B1 优先权日:2001-01-29 标题:Synthesis of energetic polyester thermoplastic homopolymers and energetic thermoplastic elastomers formed therefrom 发明人:AMPLEMAN GUY; BROCHU SYLVIE 权利人:DEPT OF NAT DEFENCE 摘要:Polymerization of α-bromomethyl-α-methyl-β-propiolactone (BMMPL) or α-chloromethyl-α-methyl-β-propiolactone (CMMPL) yielded thermoplastic homopolymers that upon azidation led to a novel energetic thermoplastic polyester: poly(α-azidomethyl-α-methyl-β-propiolactone) (PAMMPL). An energetic copolyether-ester thermoplastic elastomer was prepared by using glycidyl azide polymer, a dihydroxyl terminated energetic polymer, as a macroinitiator for the polymerization of BMMPL or CMMPL. The azidation of the resulting copolyether-ester yielded an energetic thermoplastic elastomer that melted at between 80° C. and 85° C. Polymerization of α-dibromomethyl-β-propiolactone (DBMPL) resulted in a polymer which upon azidation yielded a new energetic polymer that can be used as a binder or into an energetic thermoplastic elastomer synthesis.
专利号:US-11401273-B2 优先权日:2018-11-20 标题:Asymmetric synthesis of Azaspiro compounds 发明人:LELETI RAJENDER REDDY; WAMAN YOGESH; KALLURE PRIYA; BEGUM ZUBEDA; DIVYA THUMBAN; NALIVELA KUMARA SWAMY; VIJAY SAURABH; PARIKH PARANJAY; KOTTURI SHARADSRIKAR; PATEL CHIRAG; NAYAK KRISHNA; BAHAROONI KASIMRAZA; ZALAVADIYA VINKAL 权利人:PIRAMAL PHARMA LTD 摘要:The present invention relates to an improved asymmetric synthesis of azaspiro or diazaspiro compound (hereafter referred to as the compound 5, (5A) or (5N)) or their pharmaceutically acceptable salts and derivatives; through the formation of intermediate compounds 4, (4A) or (4N) respectively. The process comprises an unusual substrate specific highly diastereoselective as well as enantio-enriched 1-substituted 2-azaspiro[3.3]heptane or 1-substituted 2-diazaspiro[3.3]heptane compounds with high diastereoselectivity by addition of a cyclobutane carboxylate anion to a Davis-Ellman's imine, followed by reduction and cyclisation resulting in the selective formation of azaspiro or diazaspiro intermediate compound 4, (4A) or (4N); which on subsequently removing the sulfinyl group provides corresponding azaspiro or diazaspiro compound 5, (5A) or (5N) respectively.
专利号:US-10647655-B2 优先权日:2016-09-02 标题:Method for the synthesis of permethrin 发明人:PULLAGURLA MANIK REDDY; NANDA KUMAR MECHERIL VALSAN; VELIGETLA MADHUSUDHANA RAO; RANGISETTY JAGADEESH BABU 权利人:BIOPHORE INDIA PHARMACEUTICALS PVT LTD 摘要:An improved method for the synthesis of substantially pure Permethrin having purity greater than 99.5% by Gas Chromatography provided. The embodiments also relates to a purification process of Permethrin by recrystallization from methanol-water mixture.
专利号:US-9611255-B2 优先权日:2015-06-10 标题 :Process for total synthesis of flavonoid compounds and isomers thereof 发明人:RAO BATCHU VENKATESWARA; LINGAMURTHY MACHA; RAJU Gurrapu; SARMA VANKA UMAMAHESWARA 权利人:COUNCIL SCIENT IND RES; COUNCIL SCIENT IND RES 摘要:The present invention relates to the a process for total synthesis of flavonoid compounds of general formula I and isomers thereof n nwherein R 1 and R 2 is OH; R 3 â•?H orn n n n n n n n n n n The present invention particularly relates to the process for preparation and separation of (2S,3S)-taxifolin-6-C-β-D-glucopyranoside (ulmoside A), (2R,3R)-taxifolin-6-C-β-D-glucopyranoside and taxifolin.
专利号:US-5338488-A 优先权日:1992-09-10 标 题:Process for the production of synthesis gas by oxidative converson of methane (or natural gas) using composite catalyst containing transitional and alkine earth metal oxides 发明人:CHOUDHARY VASANT R; RAJPUT AMARJEET M; SANSARE SUBHASH D; PRABHAKAR BATHULA; MAMMAN AJIT S 权利人:COUNCIL OF SCIENT RESEARCH 摘要:The invention relates to a process for the production of synthesis gas by oxidative conversion of methane using composite catalysts having the formula: TmAOn, wherein T is a transition metal or metals, m is the T/A mole ratio and is from 0.01 to 100, A is an alkaline earth metal or metals, O is oxygen and n is the number of oxygen atoms needed to form a catalyst composite wherein each element of the composite has a complete set of valence electrons. In a preferred embodiment, the process includes passing a gas containing methane and oxygen over the composite catalyst in a fixed bed reactor at a pressure in the range of 0.5-50 atm, and at a temperature in the range of 200 DEG -1000 DEG C., and recovering the synthesis gas.
1: Diener HC, Grans J, Reuter U. Drugs for Migraine Prophylaxis. Dtsch Arztebl Int. 2026 Mar 6;(Forthcoming):arztebl.m2025.0234. doi: 10.3238/arztebl.m2025.0234. Epub ahead of print. 16:1708226. doi: 10.3389/fphar.2025.1708226. 3: Ladhwani NK, Bai P, Lal R, Shah AM, Bai S, Ahmed GU, Zameer R, Shaikh VF, Hyder A, Ali S, Beg MH, Adeeb M, Tesfaye M. The role of Atogepant in migraine prevention: a systematic review and meta-analysis. BMC Neurol. 2025 Sep 2;25(1):375. doi: 10.1186/s12883-025-04394-z.
合成参考文献
摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2025). 摘要:Caron, S.; Lee, J.; Liu, Y.; Nguyen, T. N.; Piper, J. L.; Vicini, A. C., Science of Synthesis: Modern Strategies in Organofluorine Chemistry, (2025) 2. 参考文献:10.1177/03331024211042385 摘要:Schwedt TJ, Lipton RB, Ailani J, Silberstein SD, Tassorelli C, Guo H, Lu K, Dabruzzo B, Miceli R, Severt L, Finnegan M, Trugman JM. Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial. Cephalalgia. 2021 Sep 14;42(1):3–11. doi: 10.1177/03331024211042385. 参考文献:10.1186/s10194-021-01360-1 摘要:Smith TR, Spierings ELH, Cady R, Hirman J, Ettrup A, Shen V. Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies. The Journal of Headache and Pain. 2021 Nov 25;22(1):143. doi: 10.1186/s10194-021-01360-1.